We are live on ! Find out more
RB

Richmond Brothers Portfolio holdings

AUM $150M
1-Year Est. Return 14.02%
This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
+14.02%
3 Year Est. Return
+102.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57.4M
AUM Growth
+$4.12M
Cap. Flow
-$1.61M
Cap. Flow %
-2.8%
Top 10 Hldgs %
91.97%
Holding
25
New
1
Increased
5
Reduced
12
Closed
2

Top Buys

Rank Stock Value
1
DRRX
DURECT Corp
DRRX
+$739K
2
GOF icon
Guggenheim Strategic Opportunities Fund
GOF
+$477K
3
HRTX icon
Heron Therapeutics
HRTX
+$213K
4
AMZN icon
Amazon
AMZN
+$7.01K
5
RMTI icon
Rockwell Medical
RMTI
+$3.91K

Top Sells

Rank Stock Value
1
MDXG icon
MiMedx Group
MDXG
+$564K
2
QQQ icon
Invesco QQQ Trust
QQQ
+$524K
3
IRD
Opus Genetics
IRD
+$341K
4
AAPL icon
Apple
AAPL
+$307K
5
IBB icon
iShares Biotechnology ETF
IBB
+$284K

Sector Composition

Rank Sector Weight
1 Healthcare 27.27%
2 Technology 14.39%
3 Financials 9.16%
4 Consumer Discretionary 1.66%
5 Communication Services 0.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
Invesco QQQ Trust
QQQ
$453B
$18.5M 32.31%
45,258
-1,380
-3% -$524K
MDXG icon
2
MiMedx Group
MDXG
$602M
$12.3M 21.47%
1,404,352
-76,980
-5% -$564K
AAPL icon
3
Apple
AAPL
$4.54T
$6.3M 10.98%
32,730
-1,665
-5% -$307K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.26M 9.16%
14,739
-701
-5% -$246K
GOF icon
5
Guggenheim Strategic Opportunities Fund
GOF
$2.23B
$3.81M 6.63%
297,281
+36,581
+14% +$477K
MSFT icon
6
Microsoft
MSFT
$3.45T
$1.96M 3.41%
5,205
-42
-0.8% -$14.9K
ARKK icon
7
ARK Innovation ETF
ARKK
$5.64B
$1.79M 3.12%
34,167
-4,373
-11% -$189K
IBB icon
8
iShares Biotechnology ETF
IBB
$9.34B
$1.26M 2.2%
9,285
-2,331
-20% -$284K
RMTI icon
9
Rockwell Medical
RMTI
$28.4M
$780K 1.36%
41,243
+208
+0.5% +$3.91K
IRD
10
Opus Genetics
IRD
$306M
$761K 1.33%
252,769
-115,234
-31% -$341K
NVG icon
11
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$612K 1.07%
51,766
-5,570
-10% -$60.5K
AMZN icon
12
Amazon
AMZN
$2.92T
$593K 1.03%
3,905
+50
+1% +$7.01K
HRTX icon
13
Heron Therapeutics
HRTX
$93.9M
$504K 0.88%
296,706
+193,697
+188% +$213K
IVV icon
14
iShares Core S&P 500 ETF
IVV
$878B
$439K 0.77%
919
– –
APLT
15
DELISTED
Applied Therapeutics
APLT
$414K 0.72%
123,654
– –
MCD icon
16
McDonald's
MCD
$192B
$356K 0.62%
1,202
-85
-7% -$23.1K
AIRI icon
17
Air Industries Group
AIRI
$13M
$318K 0.55%
97,953
-13,366
-12% -$40.3K
DRRX
18
DELISTED
DURECT Corp
DRRX
$306K 0.53%
+518,294
New +$739K
AXNX
19
DELISTED
Axonics, Inc. Common Stock
AXNX
$296K 0.52%
4,749
– –
GOOG icon
20
Alphabet (Google) Class C
GOOG
$4.36T
$281K 0.49%
1,995
+15
+0.8% +$2.04K
ONCT
21
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$265K 0.46%
24,702
– –
VZ icon
22
Verizon
VZ
$195B
$217K 0.38%
5,767
-575
-9% -$20.3K
CRGE
23
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$2.28K ﹤0.01%
20,000
– –
JNJ icon
24
Johnson & Johnson
JNJ
$618B
– –
-1,349
Closed -$210K
PG icon
25
Procter & Gamble
PG
$336B
– –
-1,549
Closed -$226K

Similar funds

CRIG
Charter Research & Investment Group Southport, Connecticut $150M AUM 28.05% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return
PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM

Richmond Brothers's Q4 2023 Portfolio in Review

As of Q4 2023, Richmond Brothers held 25 positions worth $57.4M, up 7.7% from $53.2M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Richmond Brothers's Q4 2023 filing shows 1 new, 5 increased, 12 reduced and 2 closed positions. Its largest new stake was DURECT Corp: 518,294 shares worth $306K. The largest sale was MiMedx Group, an estimated $564K.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Richmond Brothers's largest Q4 2023 buy was DURECT Corp: 518,294 shares worth $306K.
  • Richmond Brothers added most to Guggenheim Strategic Opportunities Fund in Q4 2023, an estimated $477K increase.
  • Richmond Brothers's biggest Q4 2023 reduction was MiMedx Group, cutting an estimated $564K.
  • Richmond Brothers fully exited Procter & Gamble in Q4 2023, selling an estimated $226K.
  • Richmond Brothers's ten largest holdings make up 92% of its $57.4M portfolio in Q4 2023.
  • Richmond Brothers opened 1 new position and closed 2 in Q4 2023.
  • Richmond Brothers's portfolio value rose 7.7% quarter-over-quarter to $57.4M.

Based on Richmond Brothers's 13F filing for Q4 2023, filed 8 Feb 2024.